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Abstract
Background: We aimed to develop the age- and sex-specific reference values for lipid profile of Iranian pediatric
population.
Methods: Fasting lipid profiles of 3843 participants, aged 7 to 18 years, were extracted from a surveillance survey
on Iranian children and adolescents living in 30 provinces across the country.
Results: The mean (SD) age of participants was 12.3(3.1) years, and 52.3% of them were boys. Significant
differences were observed between genders comparing the levels of triglyceride (TG) (P = 0.04), total cholesterol
(TC) (P = 0.02), low-density lipoprotein- cholesterol (LDL-C) (P = 0.01), and non-high-density lipoprotein cholesterol
(non-HDL-C) (P = 0.03). In both genders, TG levels increased with age in the 75th and higher percentiles. Among
boys, TC showed a decreasing trend at all percentiles and all age groups. In girls, TC levels increased with age at all
percentiles except for the 75th and 90th percentiles. Among boys, the levels of LDL-C and HDL-C decreased with
age in all percentiles. However, LDL-C and HDL-C concentrations increased up to the 50th percentile in girls and
then decreased with age. The non-HDL-C level decreased in the 50th and higher percentiles among boys and in
the 90th and 95th percentiles among girls. The TG/HDL-C ratio increased with age at all percentiles in boys. In girls,
TG/HDL-C ratio increased with age in the 50th and higher percentiles.
Conclusions: Based on the observed differences, it seems necessary to determine age- and sex-specific cut-off
values for lipid parameters of children and adolescents in different populations.
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Background
Dyslipidemia is one of the common problems in children
and adolescents. This condition is defined as disorders of
triglyceride (TG), high-density lipoprotein cholesterol
(HDL-C), and low-density lipoprotein cholesterol (LDL-C).
The non-HDL-C, which encompasses all atherogenic cho-
lesterols suggested as a novel predictor of cardiovascular
diseases (CVDs) which has been linked to some indicators
of metabolic syndrome in adolescents [1].
Dyslipidemia can be developed in childhood and might
lead to atherosclerotic lesions in adulthood [2] such as
increased intima-media thickness [3]. Genetic form of
hypercholesterolemia or familial hypercholesterolemia
(FH) is also an important issue in children as it can in-
crease risk of CVDs later in life [4]. This disorder has
two forms characterized by very high levels of LDL-C.
Heterozygous form of FH is more prevalent and results
in atherosclerotic signs like increased carotid intima-
media thickness from childhood [5]. Homozygous FH is
also related to premature atherosclerotic CVDs and early
death in children [6]. Although homozygous form of FH
is rare, but it is associated with extremely high risk of
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: mqorbani1379@yahoo.com; roya.kelishadi@gmail.com
†Mostafa Qorbani and Roya Kelishadi contributed equally to this work.
7Non-communicable Diseases Research Center, Alborz University of Medical
Sciences, Karaj 31485/56, Iran
6Department of Pediatrics, Child Growth and Development Research Center,
Research Institute for Primordial Prevention of Non-Communicable Disease,
Isfahan University of Medical Sciences, Isfahan, Iran
Full list of author information is available at the end of the article
Azizi-Soleiman et al. Lipids in Health and Disease           (2020) 19:16 
https://doi.org/10.1186/s12944-020-1186-1
CVDs. Its early detection and treatment can reduce the
risk of cardiovascular events. Hence, the diagnosis of
dyslipidemia is an important health issue in children and
adolescents.
Lipid levels change during different periods of child-
hood and are affected by gender and ethnicity; therefore,
lipid abnormalities in the pediatric age group should be
identified based on the percentile thresholds. According
to the guidelines of the National Cholesterol Education
Program (NCEP) and the Bogalusa Heart Study, TC,
LDL-C, non-HDL-C, and TG values of >75th percentile
are considered as borderline. Furthermore, values of
>95th percentile for the aforementioned parameters
and < 10th percentile for HDL-C are considered as ab-
normal [3, 7]. It was previously recommended to screen
dyslipidemia in children ≥2 years old who have a first or
second -degree relative (males < 55 and females < 65
years old) with confirmed CVDs or those with estab-
lished risk factors of CVDs such as overweight, diabetes,
hypertension, smoking, unhealthy diet, and inactivity [8].
According to the American Heart Association Statement
published in 2019, identification and treatment of CVD
in youth should be initiated by defining the risk level [9].
This process is based on the existence of the following
factors: children with traditional CVD risk factors in-
cluding FH, as well as childhood cancer, endocrine and
renal diseases, inflammatory disorders, underlying heart
disease, and non-communicable diseases. Thus, the risk
assessment should be done by evaluating the lipid and
glucose profile, smoking status, family history of prema-
ture CVD, as well as levels of BP, BMI, and physical
activity.
A systematic review in 2015 showed relatively high
prevalence of dyslipidemia among Iranian children and
adolescents [10]. Hence, it is of particular importance
for healthcare professionals to identify children at risk of
atherosclerosis and release of guidelines for controlling
and preventing CVDs in the future.
Studies in different populations and ethnic groups
have revealed variable cholesterol concentrations [11]. It
is reported that whites have higher levels of very low
density lipoprotein cholesterol (VLDL-C) and TG, as
well as, slightly lower HDL-C levels compared with
blacks [12]. The differences in factors like body fat dis-
tribution, activity of enzymes involved in lipid hydrolysis,
insulin response, and some specific apolipoproteins can
partly explain the interethnic differences in serum lipids
[13]. Many countries use the NCEP pediatric cutpoints
for screening the lipid disorders without consideration
of possible ethnic differences. Therefore, the diagnostic
criteria of dyslipidemia and reference values of lipid pa-
rameters should be refined based on the nationality, eth-
nicity, as well as the age and sex of individuals. This is
especially important among children and adolescents. In
the present study, we aimed to develop the age- and sex-
specific reference values for serum lipid parameters in a
representative population of Iranian children and
adolescents.
Methods
Study population
The Ethics Committee of the Isfahan University of Med-
ical Sciences approved this study. Verbal and written in-
formed consents were obtained from all participants and
their parents, respectively. The data was extracted from
the fifth survey of a surveillance program entitled Child-
hood and Adolescence Surveillance and Prevention of
Adult Non communicable disease (CASPIAN-V). It was
conducted as a nationwide study on a representative sam-
ple population of urban and rural Iranian children with 7–
18 years of age, who lived in 30 provinces across the coun-
try. Details of this study is published elsewhere [14].
Lipid profiles (TG, TC, LDL-C, HDL-C, and non-
HDL-C) of 3843 children were obtained. Children and
adolescents with history of any underlying health prob-
lem or chronic medication use were not included in the
study.
Measurements
Venous blood samples were obtained from all the sub-
jects between 7 and 9 A.M and following overnight fast-
ing. The collected samples were centrifuged and frozen
at − 70 °C. Serum lipid parameters including TC, LDL-C,
HDL-C, and TG were measured by an enzymatic
method colorimetric method using an automated
analyzer (Hitachi Automatic Analyzer 7600, Hitachi).
LDL-C was measured directly. Firstly, we used choles-
terol esterase and cholesterol oxidase to produce H2O2,
which was consumed by catalase in the presence of 4-
aminoantipyrene. Then, N, N-bis-(4-sulfobutyl)-mtolui-
dine disodium salt, buffer, and a detergent were added
to release cholesterol from LDL-C and a colored product
that is proportional to LDL-C concentration. Non-HDL-
C was calculated as “TC- HDL-C”.
Statistical analysis
Continuous and categorical variables were expressed as
mean (standard deviation, SD) and number (%), respect-
ively. The mean values of continuous variables were com-
pared between genders using independent samples
Student t test. A parametric method was used to define
the age-specific reference values by obtaining smooth cen-
tile curves and explicit formulae for the centile estimates
and SD scores (age-sex standardized values). Each param-
eter of exponential-normal or modulus-exponential-
normal density was modeled as a fractional polynomial
function of age. The estimation was based on the max-
imum likelihood. These three- and four-parameter models
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transformed the data to attain normal distribution and re-
move skewness and/or kurtosis. Fractional polynomials
provide more flexible curves than those of conventional
polynomials. Goodness of fit was assessed using Q-Q plots
and Shapiro-Wilk W-test of the SD scores. Likelihood ra-
tio test was applied as an enlarged model.
Results
The mean (SD) age of participants was 12.3 (3.1) years,
and 52.3% of them were boys. Table 1 shows the mean,
SD, and percentile values for lipid parameters in the
studied population according to their age and gender.
The mean value of TG was 85.46 (39.19) mg/dL in boys
and 88.04 (41.31) mg/dL in girls (P = 0.04). In both gen-
ders, TG levels increased with age in the 75th and higher
percentiles. Furthermore, girls had higher TG levels than
boys in all age groups (Fig. 1).
The mean value of TC was 153.02 (26.87) mg/dL in
boys and 154.93 (25.87) mg/dL in girls (P = 0.02). TC
showed a decreasing trend at all percentiles and all age
groups among boys. In girls, TC levels also increased
with age at all percentiles except for the 75th and 90th
percentiles (Fig. 2).
The overall mean value of LDL-C was 89.21 (21.91) mg/
dL in boys and 90.88 (21.71) mg/dL in girls with a signifi-
cant gender difference (P = 0.01). The overall mean value
of HDL-C was 46.14 (9.89) mg/dL in boys and 46.11
(9.68) mg/dL in girls without significant gender difference
(P = 0.92). Among boys, the levels of LDL-C and HDL-C
decreased with age in all percentiles. However, LDL-C and
HDL-C concentrations increased up to the 50th in girls
and then decreased with age (Figs. 3 and 4).
The overall mean value of non-HDL-C was 106.62
(24.69) mg/dL in boys and 108.89 (23.34) mg/dL in girls
with a significant gender difference (P = 0.03). The non-
A B
Fig. 1 Reference percentile curves for TG according to age in Iranian boys (a) and girls (b)
A B
Fig. 2 Reference percentile curves for TC according to age in Iranian boys (a) and girls (b)
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HDL-C also decreased in the 50th and higher percentiles
among boys and in the 90th and 95th percentiles among
girls (Fig. 5).
The overall mean value of the TG/HDL-C ratio was
1.97 (1.11) mg/dL in boys and 2.03 (1.19) mg/dL in girls
without significant gender difference (P = 0.10). The TG/
HDL-C ratio increased with age at all percentiles in
boys. In girls, TG/HDL-C ratio increased with age in the
50th and higher percentiles (Fig. 6).
Discussion
Our study provides reference values for serum lipid pro-
files in a nationally representative sample of Iranian
pediatric population. In general, girls had higher levels
of serum TG, TC, LDL-C, and non-HDL-C compared
with boys. TG and TG/HDL-C ratio increased with age
in both genders. As well, TC level increased with age in
girls; whereas, HDL-C and non-HDL-C levels of both
genders and TC in boys decreased with age.
Based on the reference values of lipid parameters re-
leased by the NCEP Expert Panel on Cholesterol Levels
in Children, the following thresholds have been consid-
ered to define pediatric dyslipidemia: TC ≥ 200 mg/dL,
LDL-C ≥ 130 mg/dL, HDL-C < 40 mg/dL, and non-HDL-
C ≥ 145mg/dL. Furthermore, the recommended thresh-
olds for defining hypertriglyceridemia have been ≥100
mg/dL and ≥ 130 mg/dL in children aged 0–9 and 10–
19 years, respectively [15]. In the present study, the 95th
percentiles for TC and LDL-C concentrations were close
to the values recommended by the NCEP. However,
non-HDL-C level was slightly higher in present report.
Furthermore, the 95th percentile of HDL-C was
A B
Fig. 3 Reference percentile curves for LDL-C according to age in Iranian boys (a) and girls (b)
A B
Fig. 4 Reference percentile curves for HDL-C according to age in Iranian boys (a) and girls (b)
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markedly lower, and that of TG was remarkably higher
in the present study compared with the NCEP values.
Variability in genetic background and different dietary
habits can justify these differences.
Results of the current study demonstrated some gender
differences in the reference values of serum lipid among
children and adolescents. The pathophysiology, diagnosis
and treatment of dyslipidemia in adults are different based
on gender [16]. Moreover, several studies have reported
gender differences in the levels of serum lipid parameters
in children. A study on 1000 Indian students showed that
boys had higher TC, LDL-C, and HDL-C and lower TG
levels compared with girls [17]. A study on 2283 children
and adolescents, aged 7–18 years, living in urban and rural
areas of China revealed higher prevalence of elevated TC
and LDL-C in girls than in boys. Furthermore, girls had
higher mean values of HDL-C in comparison with boys
[18]. Brazilian girls had also higher concentrations of TC
and LDL-C compared with boys [19]. These variations
may be in part due to the physiological and hormonal dif-
ferences between boys and girls.
In line with other studies, we here found that some
lipids parameters increased with age. In this regard, TG
and TG/HDL-C in both genders and TC in girls in-
creased with age in our study. In a study in Korean chil-
dren, TG/HDL-C ratio increased with age in boys and
decreased with age in girls [20]. In another study on
2141 Danish/North-European children and adolescents
aged 6–19 years old, non-HDL-C levels decreased with
age in boys [21]. In a longitudinal study on 633 children
aged 8–18 years old, TC, LDL-C, and non-HDL-C levels
in both genders and HDL-C in boys also increased with
age. Moreover, TG level showed an increasing trend in
boys during puberty [22].
A B
Fig. 5 Reference percentile curves for non-HDL-C according to age in Iranian boys (a) and girls (b)
A B
Fig. 6 Reference percentile curves for the TG/non-HDL-C according to age in Iranian boys (a) and girls (b)
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Taking together, it is recommended to define the age
and sex specific thresholds for evaluating lipid profile in
the pediatric age group, especially among children and
adolescents who are at risk of CVDs. In addition, it
should be considered that factors such as ethnicity, na-
tionality, dietary regimen, physical activity, hormonal
status, environmental factors, and socioeconomic status
can influence lipid profile in children [20, 23]. Therefore,
establishing national references for lipid parameters
should be encouraged.
This study has several strengths. To the best of our
knowledge, this survey is one of the few efforts to estab-
lish reference values for lipid parameters in a large
population-based sample of children and adolescents in
the Eastern Mediterranean region; our sample was na-
tionally- representative; and blood samples were drawn
in fasting state. There are also some limitations. Our
data was obtained based on a cross-sectional study;
moreover we were not able to evaluate the impact of pu-
bertal stage on lipid changes.
Conclusion
This study showed different thresholds for lipid parame-
ters in Iranian children and adolescents in comparison
with those presented by the NCEP. We also observed
some differences in the reference values between gen-
ders and among age groups. Since early detection of
lipid disorders in children and adolescents using refer-
ence values from other nations and ethnicities may not
be correctly performed, our results could provide
nation-specific cutpoints for screening and interpret-
ation of lipid abnormalities in Iranian pediatric popula-
tion. However, further investigations should be
conducted for defining optimal cutpoints to perform
successful interventions and strategies to manage dyslip-
idemia in the pediatric age group.
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